1. Safavi A, Azizi F, Jafari R, Chaibakhsh S, Safavi AA. Thyroid Cancer Epidemiology in Iran: a Time Trend Study. Asian Pac J Cancer Prev. 2016; 17(1): 407-12. DOI: 10.7314/apjcp.2016.17.1.407 [ DOI] [ PubMed] 2. Shah JP. Thyroid carcinoma: epidemiology, histology, and diagnosis. Clin Adv Hematol Oncol. 2015 Apr; 13(4 Suppl 4): 3-6. [ View at Publisher] 3. Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid. 2011 Mar; 21(3): 231-36. DOI: 10.1089/thy.2010.0137 [ DOI] [ PubMed] 4. Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid. 2004 Nov; 14(11): 926-32. DOI: 10.1089/thy.2004.14.926 [ DOI] [ PubMed] 5. DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. International Agency for Research on Cancer. 2004. 6. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011 Mar; 5(1): 51-56. DOI: 10.1007/s12105-010-0236-9 [ DOI] [ PubMed] 7. Memon A, Rogers I, Paudyal P, Sundin J. Dental X-Rays and the Risk of Thyroid Cancer and Meningioma: A Systematic Review and Meta-Analysis of Current Epidemiological Evidence. Thyroid. 2019 Nov; 29(11): 1572-93. DOI: 10.1089/thy.2019.0105 [ DOI] [ PubMed] 8. Memon A, Godward S, Williams D, Siddique I, Al-Saleh K. Dental x-rays and the risk of thyroid cancer: a case-control study. Acta Oncol. 2010 May; 49(4): 447-53. DOI: 10.3109/02841861003705778 [ DOI] [ PubMed] 9. diMarco A, Palazzo F. Goitre and thyroid cancer. Medicine. 2017; 45(8): 517-22. DOI: 10.1016/j.mpmed.2017.05.004 [ View at Publisher] [ DOI] 10. Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, et al. BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg. 2012 Feb; 36(2): 310-17. DOI: 10.1007/s00268-011-1383-1 [ DOI] [ PubMed] 11. Leeman-Neill RJ, Brenner AV, Little MP, Bogdanova TI, Hatch M, Zurnadzy LY, et al. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer. 2013 May; 119(10): 1792-99. DOI: 10.1002/cncr.27893 [ DOI] [ PubMed] 12. Szymańska K, Bosman FT. Thyroid Cancer. Pathology and Genetics, Diagnosis and Treatment. In: Boffetta P, Hainaut P. Encyclopedia of Cancer. 3rd ed. Oxford: Academic Press. 2018; pp: 471-82. 13. Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T, Kakudo K. Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int. 2006 May; 56(5): 240-45. DOI: 10.1111/j.1440-1827.2006.01959.x [ DOI] [ PubMed] 14. Lambert M, Jambon S, Depauw S, David-Cordonnier MH. Targeting Transcription Factors for Cancer Treatment. Molecules. 2018 Jun; 23(6): 1479. DOI: 10.3390/molecules23061479 [ DOI] [ PubMed] 15. Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer. 1989 Feb; 63(4): 718-25. DOI: 10.1002/1097-0142(19890215)63:4<718::aid-cncr2820630420>3.0.co;2-n [ DOI] [ PubMed] 16. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid. 2009 Dec; 19(12): 1351-61. DOI: 10.1089/thy.2009.0240 [ DOI] [ PubMed] 17. Adamski MG, Gumann P, Baird AE. A method for quantitative analysis of standard and high-throughput qPCR expression data based on input sample quantity. PLoS One. 2014 Aug; 9(8): e103917. DOI: 10.1371/journal.pone.0103917 [ DOI] [ PubMed] 18. Randazzo W, Vasquez-García A, Aznar R, Sánchez G. Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids. Front Microbiol. 2018 Aug; 9: 1973. DOI: 10.3389/fmicb.2018.01973 [ DOI] [ PubMed] 19. Prasad NB, Kowalski J, Tsai HL, Talbot K, Somervell K, Kouniavsky G, et al. Three-gene molecular diagnostic model for thyroid cancer. Thyroid. 2012 Mar; 22(3): 275-84. DOI: 10.1089/thy.2011.0169 [ DOI] [ PubMed] 20. Onda M, Emi M, Yoshida A, Miyamoto S, Akaishi J, Asaka S, et al. Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes. Endocr Relat Cancer. 2004 Dec; 11(4): 843-54. DOI: 10.1677/erc.1.00818 [ DOI] [ PubMed] 21. Lazzaro D, Price M, de Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development. 1991 Dec; 113(4): 1093-104. [ PubMed] 22. De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev. 2004 Oct; 25(5): 722-46. DOI: 10.1210/er.2003-0028 [ DOI] [ PubMed] 23. Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R. A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J. 1989 Sep; 8(9): 2537-42. [ PubMed] 24. Francis-Lang H, Price M, Polycarpou-Schwarz M, Di Lauro R. Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol Cell Biol. 1992 Feb; 12(2): 576-88. DOI: 10.1128/mcb.12.2.576-588.1992 [ DOI] [ PubMed] 25. Civitareale D, Castelli MP, Falasca P, Saiardi A. Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. Mol Endocrinol. 1993 Dec; 7(12): 1589-95. DOI: 10.1210/mend.7.12.8145764 [ DOI] [ PubMed] 26. Kimura S. Thyroid-specific enhancer-binding protein: Role in thyroid function and organogenesis. Trends in Endocrinology and Metabolism. 1996; 7(7): 247-52. DOI: 10.1016/S1043-2760(96)00115-4 [ Article] [ DOI] 27. Alotaibi H, Tuzlakoğlu-Öztürk M, Tazebay UH. The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation. Mol Imaging Radionucl Ther. 2017 Feb; 26(Suppl 1): 92–101. DOI: 10.4274/2017.26.suppl.11 [ DOI] [ PubMed] 28. Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R, Damante G. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res. 1994 Sep; 54(17): 4744-49. [ PubMed] 29. Sethi K, Sarkar S, Das S, Mohanty B, Mandal M. Biomarkers for the diagnosis of thyroid cancer. J Exp Ther Oncol. 2010; 8(4): 341-52. [ PubMed] 30. Kondo T, Nakazawa T, Ma D, Niu D, Mochizuki K, Kawasaki T, et al. Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas. Lab Invest. 2009 Jul; 89(7): 791-99. DOI: 10.1038/labinvest.2009.50 [ DOI] [ PubMed] |
